DMII
Drugs Made In America Acquisition II Corp.Company with tickers: DMII, DMIIR, DMIIU
CIK
2040475
CUSIP
G2851K104
Shares Outstanding
63,700,000
13F Activity (30d)
1 filings
1 filers
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $132,030 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Research & Development | — | ||||
| Operating Income | $-132,030 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Net Income | $4,337,820 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| EPS (Basic) | $0.07 | USD/shares | 2026-03-31 | 10-Q | 2026-05-14 |
| EPS (Diluted) | $0.07 | USD/shares | 2026-03-31 | 10-Q | 2026-05-14 |